Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the fourth quarter

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2017 financial and operating results after the market closes on Tuesday, March 6, 2018 . Todd M.

Filed 510(k) submission for indication expansion into laparoscopic hernia and laparoscopic cholecystectomy procedures Announces second Senhance sale in the first quarter of 2018 RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer will present at the RBC Capital Markets 2018 Global Healthcare Conference at The Lotte New York Palace Hotel in New York, New York .

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the LEERINK Partners 7th Annual Global

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today provided a year-end corporate update. "2017 was a transformational year for TransEnterix that

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the 36th Annual J.P.

Company sells SurgiBot assets to advance commercialization Company retains option to distribute SurgiBot outside of China Company expected to receive at least $29 million RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is

First Agreement to Purchase Senhance Surgical System in the US RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is pioneering the use of robotics to improve minimally invasive surgery, today announced that Florida Hospital

Received U.S. FDA 510(k) clearance for the Senhance Surgical System October 13, 2017 Cash and Restricted Cash of over $100 million as of October 31, 2017 RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is pioneering the use of